Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
2.070
-0.080 (-3.72%)
At close: Dec 5, 2025, 4:00 PM EST
2.060
-0.010 (-0.48%)
After-hours: Dec 5, 2025, 7:45 PM EST
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $18.61 million as of December 5, 2025. Its market cap has increased by 35.97% in one year.
Market Cap
18.61M
Enterprise Value
28.02M
1-Year Change
35.97%
Ranking
Category
Stock Price
$2.07
Market Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $18.61M, a decrease of -82.03%. That is a compound annual growth rate of -29.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 18.61M | -26.36% |
| Dec 31, 2024 | 25.27M | 69.64% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | 104.41M | 0.86% |
| Dec 11, 2020 | 103.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |